Moffitt Cancer Center Tampa Florida
The Moffitt Cancer Centre in Tampa, Florida, has dedicated itself to the long-term goal of finding a cure for cancer. The center’s dedicated staff works around the clock to improve patient care, conduct groundbreaking research, and educate the public about the disease.
The Moffitt Cancer Centre does not seek to make a profit. Among its many features are private patient rooms, an outpatient treatment programme, the Moffitt Research Centre, the Moffitt Cancer Centre at International Plaza, screening and prevention services, and the largest blood and marrow transplant programme in the Southeast.
We maintain a strong relationship with Moffitt Cancer Centre by offering advanced outpatient consultations to their patients and elective rotations for our fellow trainees as part of our training curriculum. This is despite the fact that only one faculty member from the Division of Digestive Diseases and Nutrition provides direct patient care.
Research at Moffitt Cancer Center
Moffitt is one of the few cancer hospitals in the world with specialists in evolutionary biology and mathematical oncology, cancer biology, computer science, and informatics working collaboratively to anticipate a tumor’s path and harness the body’s own immune system to fight cancer.
Moffitt conducted nationwide clinical trials that led to the initial FDA approvals of CAR T-cell therapy, a personalized therapy using a patient’s own immune cells to fight certain types of cancers.
Select Scientific Initiatives at Moffitt Cancer Center
Moffitt’s five multidisciplinary research programs consist of integrated teams working together to tackle the complexity of cancer. The five programs are:
Cancer Biology and Evolution, which focuses on investigating and defining the complex dynamics that govern the biology and therapeutic responses of cancer, and to deliver new agents and strategies to prevent and treat refractory or relapsed malignancies.
Cancer Epidemiology, which contributes to reducing cases of cancer through research to identify risk factors across the cancer continuum comprising etiology, progression, and outcome, and the translation of that knowledge into successful prevention and early detection interventions.
Chemical Biology and Molecular Medicine, which integrates chemical biology and systems biology technologies to develop new therapeutic approaches for the treatment of cancer.
Health Outcomes and Behavior, which contributes to the prevention, detection, and control of cancer through the study of health-related behaviors, health care practices, and health-related quality of life.
Immunology, which applies basic research findings to the treatment of human malignancies to develop and deliver advanced clinical immunotherapies that benefit cancer patients. The goal is achieved through close integration of basic, translational, and clinical researchers to discover basic mechanisms and rapidly translate them from the bench to the bedside.
Two of the programs, Cancer Biology & Evolution and Immunology, accrue more than 1,000 patients for treatment a year.
